Endocrine Tumor Board is designed to review existing cases and apply the most current evidence-based knowledge and guidelines to establish treatment plans for improved patient outcomes.

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

• Decide when surgery, chemo and/or radiation should be used for treatment for the specific patients
• Introduce new pathological tests that can provide prognostic indicators for treatment decisions
• Identify new drugs and/or treatment modalities and formulate the best treatment plan for patient cases discussed
• Review the latest NCCN Guidelines and ASCO Guidelines
   

PLANNER/MODERATOR DISCLOSURE: The planners have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Christy Morgan at [email protected] 

Meeting Link: